Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2003
12/31/2003CN1463703A Nasal cavity preparation for treating long-term allergic reaction coryza
12/31/2003CN1463698A Oral preparation compound containing Fudosteine
12/31/2003CN1463610A Process for making liquorice tea
12/31/2003CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process
12/31/2003CN1132611C Chinese medicine for treating chronic laryingitis and vocal fold node and process for preparing its granular medicine
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490626A1 Prodrug, medicinal utilization thereof and process for producing the same
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003CA2489528A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670381 Benzamide derivatives as thrombin inhibitors
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670370 Cough suppression; reacting dextromethorphan with tannic acid
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670357 Antiinflammatory agents
12/30/2003US6670349 Asthma
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2280940C Use of plant extract for inhibition of haemophilus influenzae
12/30/2003CA2146723C Percutaneous absorption preparation
12/25/2003WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236238 Respiratory system disorders; asthma; stable powder form of formoterol; storage stability
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235616 Pharmaceutical pills comprising drugs such as non-steroidal antiinflammatory agents, and cores surrounded by shells, having apertures for timed or sustained drug delivery
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/24/2003WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106451A1 Substituted diaminopyrimidines
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106403A1 Carboxamides derivatives
12/24/2003WO2003105908A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/24/2003WO2003105907A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
12/24/2003WO2003105893A2 Probiotic therapies
12/24/2003WO2003105885A1 Novel method of screening
12/24/2003WO2003105884A1 Use of shp-1 for the therapy of asthma
12/24/2003WO2003105872A1 Anti-spasmodic comprising xenon
12/24/2003WO2003105859A1 Powdery respiratory tonic composition
12/24/2003WO2003105856A1 Combination of azelastine and steroids
12/24/2003WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/24/2003WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
12/24/2003WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
12/24/2003WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
12/24/2003WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
12/24/2003WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
12/24/2003WO2003084519A3 Aerosol formulation for inhalation comprising a tiotropium salt
12/24/2003WO2003077892A3 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases
12/24/2003WO2003075926A8 Use of proton pump inhibitors for the treatment of airway disorders
12/24/2003WO2003075827A3 Use of mycobacterium w in the treatment of asthama(obstructive lung disease)
12/24/2003WO2003075824A3 Process of manufacturing pharmaceutical composition useful for management of tuberculosis
12/24/2003WO2003074025A3 Pressurised metered dose inhalers containing solutions of beta-2 agonists
12/24/2003WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/24/2003WO2003070182A3 Sodium channel blockers
12/24/2003WO2003070153A3 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/24/2003WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/24/2003WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
12/24/2003WO2003065044A8 Diagnostics and therapeutics for diseases associated with gpr72
12/24/2003WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene
12/24/2003WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists
12/24/2003WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
12/24/2003WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/24/2003WO2003035137A3 Method and apparatus for dispensing inhalator medicament
12/24/2003WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications
12/24/2003CN1462755A Method for distilling active protein liquid of scorpion
12/24/2003CN1462631A Medicine combination containing white atractylodes rhizome and its preparation method
12/24/2003CN1462627A Chinese herbal medicine prescription for prevention and treatment of atypical pneumonia